Monte Rosa Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 06/08/2026 | Mar 2026Filed 06/08/2026 | Sep 2025Filed 06/11/2025 | Jun 2025Filed 06/08/2026 | Mar 2025Filed 06/08/2026 | Sep 2024Filed 06/11/2025 | Jun 2024Filed 06/11/2025 | Mar 2024Filed 06/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $9 | $4.2 | $13 | $23 | $85 | $9.2 | $4.7 | $1.1 | |
| −$43 | −$45 | −$27 | −$12 | $47 | −$24 | −$30 | −$32 | |
| 101 | 100 | 82 | 82 | 83 | 82 | 71 | 60 |
Trend